NEW YORK, Jan. 31, 2022 /PRNewswire/ — Attention Organogenesis Holdings Inc. (“Organogenesis”) (NASDAQ: ORGO) shareholders:
The Law Offices of Vincent Wong announce that a class action lawsuit has commenced on behalf of investors who purchased ORGO between March 17, 2021 and October 11, 2021
If you suffered a loss on your investment in Organogenesis, contact us about potential recovery by using the link below. There is no cost or obligation to you.
The class action against Organogenesis includes allegations that the Company made materially false and/or misleading statements and/or failed to disclose that: (i) Organogenesis improperly billed the federal government for its Affinity and PuraPly XT products by, among other things, setting the price for those products multiple times higher than similar products; (ii) the Company improperly induced doctors to use its Affinity and PuraPly XT products through lucrative reimbursements; (iii) as a result of all the foregoing, the Company's revenue and profits derived from its Affinity and PuraPly XT products were at least in substantial part unsustainable; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times.
DEADLINE: February 8, 2022
Aggrieved Organogenesis investors only have until February 8, 2022 to request that the Court appoint you as lead plaintiff. You are not required to act as a lead plaintiff in order to share in any recovery.
Vincent Wong, Esq. is an experienced attorney who has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.
Vincent Wong, Esq.
39 East Broadway
New York, NY 10002
View original content:https://www.prnewswire.com/news-releases/class-action-alert-the-law-offices-of-vincent-wong-remind-organogenesis-investors-of-a-lead-plaintiff-deadline-of-february-8-2022-301471813.html
SOURCE The Law Offices of Vincent Wong